skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Adult remover assunto: Breast Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial

Velikova, Galina ; Williams, Linda Jane ; Willis, Sarah ; Dixon, J Michael ; Loncaster, Juliette ; Hatton, Matthew ; Kunkler, Ian H ; Russell, Nicola S ; Alhasso, A ; Adamson, D ; Algurafi, H ; Allerton, R ; Anandadas, C ; Bahl, A ; Barraclough, L ; Barrett-Lee, P ; Barthakur, U ; Bedi, C ; Beresford, M ; Bishop, J ; Blackman, G ; Bliss, P ; Bloomfield, D ; Blunt, M ; Branson, T ; Brazil, L ; Brunt, A ; Chakrabarti, A ; Chittalie, A ; Churn, M ; Clarke, J ; Cleator, S ; Crellin, P ; Danwata, F ; De-Silva-Minor, S ; Dhadda, A ; Eicholz, A ; Fernando, I ; Forrest, J ; Fraser, J ; Geropantas, K ; Goodman, A ; Grieve, R ; Griffin, M ; Hadaki, M ; Hall, A ; Hatton, M ; Hicks, J ; Hignett, S ; Hogg, M ; Jyothirmayi, R ; Khan, M ; Kumar, S ; Lawton, P ; Lee, D ; Lim, C ; Locke, I ; Loncaster, J ; Lumsden, G ; Lupton, S ; Magee, B ; Marshall, J ; Masinghe, S ; McGregor, C ; McLennan, M ; Memtsa, P ; Milanovic, D ; Misra, V ; Mithal, N ; Mukesh, MB ; Neal, A ; Needleman, S ; Persic, M ; Quigley, M ; Raj, S ; Riddle, P ; Ritchie, D ; Roberts, F ; Roe, H ; Rolles, M ; Shah, N ; Sharma, R ; Simmonds, P ; Skailles, G ; Skaria, S ; Soe, W ; Sripadam, R ; Stevens, A ; Stockdale, A ; Storey, N ; Syndikus, I ; Thorp, N ; Upadhyay, S ; Varughese, M ; Walji, N ; Welch, R ; Wells, T ; Wolstenholme, V ; Woodings, P ; Yuille, F

The lancet oncology, 2018-11, Vol.19 (11), p.1516-1529 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Murray Brunt, Adrian ; Haviland, Joanne S ; Wheatley, Duncan A ; Sydenham, Mark A ; Alhasso, Abdulla ; Bloomfield, David J ; Chan, Charlie ; Churn, Mark ; Cleator, Susan ; Coles, Charlotte E ; Goodman, Andrew ; Harnett, Adrian ; Hopwood, Penelope ; Kirby, Anna M ; Kirwan, Cliona C ; Morris, Carolyn ; Nabi, Zohal ; Sawyer, Elinor ; Somaiah, Navita ; Stones, Liba ; Syndikus, Isabel ; Bliss, Judith M ; Yarnold, John R ; Alhasso, Abdulla ; Armstrong, Anne ; Bliss, Judith ; Bloomfield, David ; Bowen, Jo ; Brunt, Murray ; Chan, Charlie ; Chantler, Hannah ; Churn, Mark ; Cleator, Susan ; Coles, Charlotte ; Donovan, Ellen ; Goodman, Andy ; Griffin, Susan ; Haviland, Jo ; Hopwood, Penny ; Kirby, Anna ; Kirk, Julie ; Kirwan, Cliona ; MacLennan, Marjory ; Morris, Carolyn ; Nabi, Zohal ; Sawyer, Elinor ; Sculphur, Mark ; Sinclair, Judith ; Somaiah, Navita ; Stones, Liba ; Sydenham, Mark ; Syndikus, Isabel ; Tremlett, Jean ; Venables, Karen ; Wheatley, Duncan ; Yarnold, John

The Lancet (British edition), 2020-05, Vol.395 (10237), p.1613-1626 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab

Lin, Nancy U. ; Winer, Eric P. ; Wheatley, Duncan ; Carey, Lisa A. ; Houston, Stephen ; Mendelson, David ; Munster, Pamela ; Frakes, Laurie ; Kelly, Steve ; Garcia, Agustin A. ; Cleator, Susan ; Uttenreuther-Fischer, Martina ; Jones, Hilary ; Wind, Sven ; Vinisko, Richard ; Hickish, Tamas

Breast cancer research and treatment, 2012-06, Vol.133 (3), p.1057-1065 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
4
Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival
Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival
Material Type:
Artigo 		Adicionar ao Meu Espaço

Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival

Cleator, S. J. ; Makris, A. ; Ashley, S. E. ; Lal, R. ; Powles, T. J.

Annals of oncology, 2005-02, Vol.16 (2), p.267-272 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
5
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy

PIERGA, J.-Y ; REIS-FILHO, J. S ; JONES, C ; ASHWORTH, A ; SMITH, I. E ; POWLES, T ; DOWSETT, M ; CLEATOR, S. J ; DEXTER, T ; MACKAY, A ; SIMPSON, P ; FENWICK, K ; IRAVANI, M ; SALTER, J ; HILLS, M

British journal of cancer, 2007-01, Vol.96 (2), p.341-351 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer

Kotwinski, Paul ; Smith, Gillian ; Cooper, Jackie ; Sanders, Julie ; Ma, Louise ; Teis, Albert ; Kotwinski, David ; Mythen, Michael ; Pennell, Dudley J ; Jones, Alison ; Montgomery, Hugh Bishopric, Nanette H.

PloS one, 2016-12, Vol.11 (12), p.e0165262 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
7
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance

CLEATOR, Susan ; TSIMELZON, Anna ; CHANG, Jenny C ; ASHWORTH, Alan ; DOWSETT, Mitch ; DEXTER, Timothy ; POWLES, Trevor ; HILSENBECK, Susan ; WONG, Helen ; OSBORNE, C. Kent ; O'CONNELL, Peter

Breast cancer research and treatment, 2006-02, Vol.95 (3), p.229-233 [Periódico revisado por pares]

Dordrecht: Springer

Texto completo disponível

Citações Citado por
8
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

Palmieri, C. ; Cleator, S. ; Kilburn, L. S. ; Kim, S. B. ; Ahn, S.-H. ; Beresford, M. ; Gong, G. ; Mansi, J. ; Mallon, E. ; Reed, S. ; Mousa, K. ; Fallowfield, L. ; Cheang, M. ; Morden, J. ; Page, K. ; Guttery, D. S. ; Rghebi, B. ; Primrose, L. ; Shaw, J. A. ; Thompson, A. M. ; Bliss, J. M. ; Coombes, R. C.

Breast cancer research and treatment, 2014-12, Vol.148 (3), p.581-590 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
9
Adequacy of diagnostic tests and surgical management of symptomatic invasive lobular carcinoma of the breast
Adequacy of diagnostic tests and surgical management of symptomatic invasive lobular carcinoma of the breast
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adequacy of diagnostic tests and surgical management of symptomatic invasive lobular carcinoma of the breast

Hadjiminas, D J ; Zacharioudakis, K E ; Tasoulis, M K ; Hu, J C C ; Lanitis, S ; Bright-Thomas, R ; Dimopoulos, N G ; Hornzee, G ; Cunningham, D A ; Cleator, S J ; Al Mufti, R

Annals of the Royal College of Surgeons of England, 2015-11, Vol.97 (8), p.578-583 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
10
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Hiller, Louise ; Vallier, Anne-Laure ; McAdam, Karen ; Hughes-Davies, Luke ; Ah-See, Mei-Lin ; Simcock, Richard ; Rea, Daniel ; Raj, Sanjay ; Woodings, Pamela ; Harries, Mark ; Raynes, Kerry ; Higgins, Helen B ; Plummer, Chris ; Mansi, Janine ; Mahler–Araujo, Betania ; Abraham, Jean E ; Caldas, Carlos ; McCabe, Christopher ; Miles, David ; Wardley, Andrew M ; Cameron, David A ; Agarwal, Roshan ; Algurafi, Hafiz ; Archer, Caroline ; Armstrong, Anne ; Bale, Catherine ; Barraclough, Lisa ; Barthakur, Urmila ; Bedi, Carolyn ; Benstead, Kim ; Bloomfield, David ; Bowen, Rebecca ; Bradley, Chris ; Brown, Jane ; Butt, Mohammad ; Churn, Mark ; Cleator, Susan ; Cliff, Joanne ; Crellin, Perric ; Daly, Margaret ; De Silva-Minor, Shiroma ; Dhadda, Amandeep ; Din, Omar ; Down, Sue ; Earl, Helena ; Eaton, David ; Eichholz, Andrew ; Epurescu, Daniel ; Goh, Chee ; Goodman, Andrew ; Grieve, Robert ; Hadaki, Maher ; Harper-Wynne, Catherine ; Harries, Mark ; Hayward, Larry ; Humphreys, Alison ; Innes, Helen ; Jafri, Mariam ; Jegannathen, Apurna ; Kelleher, Muireann ; Kristeleit, Hartmut ; Lee, Daniela ; Lupton, Susan ; MacGregor, Carol ; Malik, Zafar ; Mansi, Janine ; Marshall, Jennifer ; McAdam, Karen ; McGolick, Trevor ; Mehra, Rakesh ; Miles, David ; Mithal, Natasha ; Moss, Charlotte ; Moss, Aian ; Nelmes, Daniel ; Neville-Webbe, Helen ; Newby, Jacqueline ; O'Reilly, Susan ; Ostler, Peter ; Persic, Mojca ; Pettit, Laura ; Raj, Sanjay ; Raja, Fharat ; Rea, Daniel ; Reed, Catherine ; Rigg, Anne ; Roe, Helen ; Shah, Nihal ; Simmonds, Peter ; Sims, Eliot ; Smith, Sarah ; Storey, Nicola ; Taylor, Wendy ; Tipples, Karen ; Vaidya, Jayant ; Varughese, Mohini ; Walji, Nawaz ; Woodings, Pamela ; Wright, Kathryn ; Yahya, Sundus

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2599-2612 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (147)

Data de Publicação 

De até
Refinar
  1. Antes de2006  (5)
  2. 2006Até2009  (38)
  3. 2010Até2013  (51)
  4. 2014Até2018  (38)
  5. Após 2018  (19)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.